And now the Ebola outbreak… are you scared yet?

Fortunately Ebola is not a terribly contagious disease so that once appropriate containment resources became available thing began to wind down. Controlling a disease like Ebola takes a commitment on the part of authorities to educate and contain.
The CDC and the medical community was telling everyone this from the start but the media didn’t want to hear it because it was better for ratings to make it sound like an unstoppable epidemic that threatened us all. Thankfully the worlds governments and the WHO did what they do best and have nearly brought the epidemic to an end.

Ebola is so 2014. An update line from one of the above links: “More than 12 months after the largest ever Ebola outbreak began, the situation is improving and continued gains are headed towards the end of ongoing activity. Liberia’s outbreak was declared over on 9 May, and transmission continues to decline in Guinea and Sierra Leone.”
Actually the disease was set to grow exponentially, if a massive effort were not put underway. But a massive response was and is being put underway.
How the heck is Obama going to be able to bring on the end times, if so many medical personnel and governmental and social agencies keep behaving so responsibly?

Hey check it out. The march of science continues:

PUBLIC RELEASE: 10-MAY-2015 Damming and damning hemorrhagic diseases Rift Valley fever virus' proteins imitate human DNA repair factors, say University of Montreal scientists. Using drugs to dam this chemical reaction would condemn the disease's infectiousness UNIVERSITY OF MONTREAL A potential mechanism to combat diseases caused by haemorrhagic fever viruses has been discovered by researchers at the University of Montreal's Department of Biochemistry and Molecular Medicine. These diseases present a dramatic risk to human health as they often spread quickly and kill a high percentage of infected individuals, as demonstrated by the recent Ebola outbreaks. Effective treatments such as vaccines and drug therapies are not available for many of these infections since the outbreaks mostly occur in developing countries with limited financial resources. Moreover, the genomes of many haemorrhagic fever viruses mutate rapidly, enabling them to quickly adapt to potential drug treatments and evade the immune system. "Although our work does not directly lead to treatments on a short term, it does identify a process where the virus could be vulnerable to drug therapy, or how we might design an attenuated viral strain for vaccine development," said first author Normand Cyr, a postdoctoral researcher. "Identification of the Achilles heels of haemorrhagic fever viruses like the Rift Valley fever virus will help inspire additional research and eventually lead to the development of new therapeutic strategies to treat these deadly tropical infections." The research was supervised by senior co-author Professor James Omichinski and published in the Proceedings of the National Academy of Sciences of the USA (PNAS). …